InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Nukemtiltheyglow post# 30307

Friday, 07/04/2014 10:14:13 AM

Friday, July 04, 2014 10:14:13 AM

Post# of 426505
P&L breakevenn at 25k weekly script with
- 164M revenue
- 65% GM (after KOWA fee)
- 26,8M OPEX (Q1 was 32,3M

Marine: Do not forget that Lovaza's label contains "ANCHOR" trial data till 2014 and was the only drug in class
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News